Biomarkers plus guidelines to reduce unnecessary brain CTs after head injury
Official title: Comparing the Effectiveness of a Biomarker-plus-clinical Guidelines Algorithm Versus Clinical Guidelines Only for Safely Decreasing Brain Computed Tomography Utilization During Brain Injury Evaluations: The PIONEER Comparative Effectiveness Study
Run by University of Michigan · NCT07829107 · Data updated 2026-11-12
This trial tests whether adding GFAP and UCH-L1 biomarker results to standard guidelines can safely reduce head CT scans in adults with suspected traumatic brain injury who come to the emergency department.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | University of Michigan Academic / other |
| Locations | 6 sites (Sylmar, California and 5 other locations) |
| Status | Recruiting |
| Started | October 15, 2026 |
| Main results expected | January 2029 |
| Study ends | January 2029 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07829107 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older presenting to participating EDs with suspected TBI and GCS 13-15 within 24 hours of injury.
✕Probably not a fit
Patients whose imaging decisions are not influenced by biomarkers or who have injuries requiring immediate imaging regardless of biomarkers.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic, open-label study uses a stepped-wedge design across six emergency departments to compare biomarker-guided pathways with guideline-only care for suspected traumatic brain injury. Biomarkers GFAP and UCH-L1 are used alongside clinical guidelines to decide whether a CT scan is needed. The study begins with usual care, then progressively implements the biomarker-guided algorithm at different sites over 24 months to assess real-world effectiveness and implementation feasibility. The primary focus is on reducing low-value CT imaging while maintaining patient safety. Eligible participants are adults 18 or older with suspected TBI and a GCS of 13-15 presenting within 24 hours of injury.
Why it matters
Potential benefit: If successful, patients may experience fewer unnecessary brain CT scans without compromising safety, reducing radiation exposure and resource use.
How similar studies have gone: Previous similar approaches in other settings have shown potential to safely reduce imaging with biomarker-guided pathways, though this exact design is novel in ED TBI care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion * Age ≥18 years at the time of the emergency department visit. * Presentation to a participating emergency department following a traumatic injury mechanism (motor vehicle collision, fall from height, assault, head injury/head trauma/head strike, struck by or against an object, facial injury or laceration, or other general trauma). Presentations may also include alcohol intoxication or syncope when associated with a suspected traumatic brain injury. * Evidence of potential head or brain injury, defined as (i) the head being struck by an object, (ii) the head striking a hard object or surface, (iii) exposure of the brain to significant acceleration/deceleration forces, or (iv) clinician documentation that the patient was evaluated for suspected traumatic brain injury. * Glasgow Coma Scale (GCS) score of 13-15 at presentation. * Presentation to the emergency department within 24 hours of injury. Exclusion Criteria: * Planned computed tomography (CT) imaging of the maxillofacial bones, chest, abdomen, or pelvis during the ED encounter AND clinicians do not intend to avoid brain CT imaging even if the biomarker test is negative. * Current use of anticoagulant or antiplatelet therapy, including but not limited to: Warfarin, Factor Xa inhibitors (e.g., apixaban \[Eliquis\], rivaroxaban \[Xarelto\]), Clopidogrel, Ticagrelor. * Presentation \>24 hours after injury, due to the declining diagnostic sensitivity of Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) beyond this time window.
Where it's running
-
UCLA-Olive View Medical Center
Sylmar, California, United States Recruiting -
Harbor-UCLA Medical Center
Torrance, California, United States Recruiting -
Henry Ford Macomb (HFM)
Clinton Township, Michigan, United States Recruiting -
Henry Ford Hospital (HFH)
Detroit, Michigan, United States Recruiting -
Hillsboro Medical Center
Portland, Oregon, United States Recruiting -
Oregon Health & Science University (OHSU)
Portland, Oregon, United States Recruiting
Study contacts
- Principal investigator: Frederick Korley, MD, PhD — University of Michigan
- Study coordinator: Devon Newman, MS
- Email: devonn@med.umich.edu
- Phone: 734-652-9679
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ecological Test Standardization for Concussion Assessment in Football Players
A study tests an ecological, real-world cognitive assessment battery to see if it reliably detects concussions in professional and youth football players.
-
Treatment and outcomes after mild head injury
Researchers are looking at past emergency department records to see how often adults with mild head injury develop serious complications and whether the Canadian CT Head Rule or the NEXUS Head CT better predicts who will need surgery or die.
-
Osteopathic treatment for head injuries in MMA fighters
This study tests if osteopathic treatment can help MMA fighters recover better from head injuries and improve their thinking skills after a concussion.
-
Assessing mental health risks in adolescents with mild traumatic brain injury
This study is trying to create a tool that helps doctors predict which teens aged 11 to 17 who have had a mild brain injury might develop new or worsening mental health issues.
-
Evaluating the necessity of CT-scans for head injury patients on platelet inhibitors
This study is testing if patients with minor head injuries who are on blood-thinning medications really need a CT-scan to check for bleeding in the brain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.